Skip to content
AnalystLens
Back to VRTXIncome Statement

VERTEX PHARMACEUTICALS INC / MA Gross Profit 2010-2026 | VRTX

Annual FY2010–FY2025 · quarterly through Q1 FY2026

Latest annual · FY2025

$10.35B

+9.1%YoY vs FY2024Source: 10-KFY2025

From $143.4M in FY2010 to $10.35B in FY2025: 72.2× in 15 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$2.6B+7.8%Not reportedNot reportedNot reported
FY25$2.4B+2.5%$2.6B+12.5%$2.7B+11.9%$2.7B+9.5%
FY24$2.3B+11.4%$2.3B+4.1%$2.4B+9.9%$2.5B+15.8%
FY23$2.1B+13.8%$2.2B+12.9%$2.2B+5.9%$2.1B+6.5%
FY22$1.9B+20.9%$1.9B+23.6%$2.0B+17.0%$2.0B+10.6%
Share24%24%25%27%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date. Share: its typical part of the fiscal year.

Key Statistics

Trend DirectionGrowing
CAGR

+13.6%

FY2020
$5.47B
FY2025
$10.35B

5 years selected · on the chart

01—History

Gross Profit History

Year-over-year comparison from 10-K annual reports

  16. $10.35B
YoY changeLargest recent move+63.0%in FY16Latest +9.1%

1 older move runs past ±100% (largest +839.5%); point at, tap or drag across the bars to read one.

02—Ledger

Gross Profit, period by period

PeriodValueChangeSource
FY2025$10.35B+9.1%10-K
FY2024$9.49B+10.3%10-K
FY2023$8.61B+9.6%10-K
FY2022$7.85B+17.7%10-K
FY2021$6.67B+22.0%10-K
FY2020$5.47B+51.3%10-K
FY2019$3.62B+37.0%10-K
FY2018$2.64B+19.0%10-K
FY2017$2.22B+48.6%10-K
FY2016$1.49B+63.0%10-K
FY2015$915.2M+69.3%10-K
FY2014$540.7M−51.9%10-K
FY2013$1.12B−13.0%10-K
FY2012$1.29B−4.2%10-K
FY2011$1.35B+839.5%10-K
FY2010$143.4M—10-K

03—Questions

What is gross profit?

Gross profit can be defined as revenue minus the cost of goods sold, representing the profit a company makes before deducting operating expenses.

What is VERTEX PHARMACEUTICALS INC / MA's current gross profit?

VERTEX PHARMACEUTICALS INC / MA (VRTX) annual gross profit for 2025 was $10.35B, a 9.07% increase from 2024. VERTEX PHARMACEUTICALS INC / MA gross profit for the quarter ending March 31, 2026 was $2.59B.

What was VERTEX PHARMACEUTICALS INC / MA's gross profit in 2024?

VERTEX PHARMACEUTICALS INC / MA annual gross profit for 2024 was $9.49B, a 10.25% increase from 2023.

What was VERTEX PHARMACEUTICALS INC / MA's gross profit in 2023?

VERTEX PHARMACEUTICALS INC / MA annual gross profit for 2023 was $8.61B, a 9.64% increase from 2022.

What is VERTEX PHARMACEUTICALS INC / MA's 5-year gross profit CAGR?

VERTEX PHARMACEUTICALS INC / MA gross profit grew at a compound annual growth rate (CAGR) of 13.61% from FY2020 to FY2025, going from $5.47B to $10.35B over 5 years.

Company
VERTEX PHARMACEUTICALS INC / MA
Ticker
VRTX
Sector
Healthcare
Industry
Pharmaceutical Preparations
View company profile →